Syndax Pharmaceuticals Inc
SNDXHealthcare|Biotechnology|USA
$23.62
-1.23 (-4.95%)
Tangible Book
$0.47
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (75)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Metzger Michael A | CEO | 2026-07-08 | SELL | 32,375 | $24.24 | $784.8K |
| Botwood Nicholas A.J. | Head of R&D, CMO | 2026-06-12 | SELL | 65,515 | $18.07 | $1183.9K |
| Metzger Michael A | CEO | 2026-06-01 | SELL | 6,847 | $18.99 | $130K |
| Goldan Keith A. | CFO | 2026-06-01 | SELL | 1,177 | $18.99 | $22.4K |
| Metzger Michael A | CEO | 2026-02-09 | SELL | 17,159 | $21.03 | $360.9K |
| Goldan Keith A. | CFO | 2026-02-09 | SELL | 3,410 | $21.03 | $71.7K |
| Metzger Michael A | CEO | 2026-02-06 | SELL | 7,412 | $20.62 | $152.8K |
| Goldan Keith A. | CFO | 2026-02-06 | SELL | 2,082 | $20.62 | $42.9K |
| Metzger Michael A | CEO | 2025-09-08 | SELL | 157,307 | $16.41 | $2581.4K |
| Podlesak Dennis | Director | 2025-08-18 | SELL | 57,600 | $15.19 | $874.9K |
| Goldan Keith A. | CFO | 2025-07-16 | SELL | 1,296 | $9.29 | $12K |
| Metzger Michael A | CEO | 2025-07-16 | SELL | 7,534 | $9.29 | $70K |
| Katkin Keith | Director | 2025-05-19 | BUY | 10,000 | $9.11 | $91.1K |
| Huber Martin H. Jr. | Director | 2025-05-19 | BUY | 5,000 | $8.99 | $45K |
| Botwood Nicholas A.J. | Head of R&D, CMO | 2025-05-16 | BUY | 11,765 | $9 | $105.9K |
| Metzger Michael A | CEO | 2025-03-04 | SELL | 7,814 | $15.05 | $117.6K |
| Goldan Keith A. | CFO | 2025-02-10 | SELL | 3,777 | $15.5 | $58.5K |
| Metzger Michael A | CEO | 2025-02-10 | SELL | 13,288 | $15.5 | $206K |
| Gallagher Neil | President, Head of R&D | 2025-02-10 | SELL | 4,618 | $15.5 | $71.6K |
| Goldan Keith A. | CFO | 2024-06-14 | BUY | 1,250 | $20.03 | $25K |
| Morrison Briggs | Director | 2023-08-09 | SELL | 52,855 | $18.27 | $965.7K |
| Meury William | Director | 2023-08-02 | SELL | 83,000 | $20.46 | $1698.2K |
| Morrison Briggs | Director | 2023-07-10 | SELL | 52,855 | $20.4 | $1078.2K |
| Goldan Keith A. | CFO | 2023-06-13 | SELL | 577 | $22.31 | $12.9K |
| Morrison Briggs | Director | 2023-06-09 | SELL | 52,855 | $21.18 | $1119.5K |
| Morrison Briggs | Director | 2023-05-09 | SELL | 52,855 | $21.41 | $1131.6K |
| Morrison Briggs | Director | 2023-04-10 | SELL | 52,855 | $19.53 | $1032.3K |
| Morrison Briggs | President, Head of R&D | 2023-03-13 | SELL | 52,854 | $22.53 | $1190.8K |
| Ordentlich Peter | Chief Scientific Officer | 2023-02-15 | SELL | 25,000 | $25.84 | $646K |
| Metzger Michael A | CEO | 2023-02-06 | SELL | 5,959 | $27.64 | $164.7K |
| Morrison Briggs | President, Head of R&D | 2023-02-06 | SELL | 52,854 | $26.83 | $1418.1K |
| Ordentlich Peter | Chief Scientific Officer | 2023-02-01 | SELL | 69 | $28.43 | $2K |
| Legault Pierre | Director | 2023-01-13 | SELL | 39,000 | $26.84 | $1046.8K |
| Ordentlich Peter | Chief Scientific Officer | 2022-12-02 | SELL | 25,000 | $25.04 | $626K |
| Katkin Keith | Director | 2022-10-06 | SELL | 29,899 | $25.9 | $774.4K |
| Metzger Michael A | CEO | 2022-10-06 | SELL | 16,231 | $25.29 | $410.5K |
| Metzger Michael A | CEO | 2022-10-04 | SELL | 33,769 | $25.02 | $844.9K |
| Katkin Keith | Director | 2022-10-04 | SELL | 4,101 | $25.06 | $102.8K |
| Morrison Briggs | President, Head of R&D | 2022-09-20 | SELL | 173,988 | $23.11 | $4020.9K |
| Morrison Briggs | President, Head of R&D | 2022-09-16 | SELL | 279,420 | $23.64 | $6605.5K |
| Podlesak Dennis | Director | 2022-09-16 | SELL | 78,815 | $24.08 | $1897.9K |
| Ordentlich Peter | Chief Scientific Officer | 2022-08-24 | SELL | 25,000 | $25.04 | $626K |
| Metzger Michael A | CEO | 2022-07-25 | SELL | 31,602 | $21.06 | $665.5K |
| Metzger Michael A | CEO | 2022-07-07 | SELL | 15,109 | $21.07 | $318.3K |
| Ordentlich Peter | Chief Scientific Officer | 2022-02-01 | SELL | 1,412 | $16.65 | $23.5K |
| Nolte Alexander | Chief Accounting Officer | 2022-02-01 | SELL | 968 | $16.65 | $16.1K |
| Legault Pierre | Director | 2021-12-22 | SELL | 44,000 | $21.56 | $948.6K |
| Metzger Michael A | President and COO | 2021-12-20 | SELL | 85,391 | $19.94 | $1702.7K |
| Morrison Briggs | CEO | 2021-12-17 | SELL | 35,156 | $20 | $703.1K |
| Metzger Michael A | President and COO | 2021-12-13 | SELL | 36,609 | $19.05 | $697.4K |
| Egros Fabrice | Director | 2021-11-18 | SELL | 14,030 | $18.03 | $253K |
| Metzger Michael A | President and COO | 2021-10-26 | SELL | 61,000 | $19.15 | $1168.2K |
| Metzger Michael A | President and COO | 2021-09-27 | SELL | 24,437 | $19.51 | $476.8K |
| Metzger Michael A | President and COO | 2021-09-22 | SELL | 36,563 | $19.22 | $702.7K |
| Morrison Briggs | CEO | 2021-09-20 | SELL | 70,312 | $20.07 | $1411.2K |
| Metzger Michael A | President and COO | 2021-09-14 | SELL | 61,000 | $19.12 | $1166.3K |
| Egros Fabrice | Director | 2021-08-18 | SELL | 15,635 | $15.75 | $246.3K |
| Egros Fabrice | Director | 2021-05-18 | SELL | 13,609 | $18.65 | $253.8K |
| Podlesak Dennis | Director | 2021-04-22 | BUY | 13,967 | $14.11 | $197.1K |
| Egros Fabrice | Director | 2021-03-01 | SELL | 10,241 | $24.31 | $249K |
| Morrison Briggs | CEO | 2021-02-08 | SELL | 35,156 | $20.55 | $722.5K |
| Metzger Michael A | President and COO | 2021-02-01 | SELL | 15,000 | $20.19 | $302.9K |
| Metzger Michael A | President and COO | 2020-12-01 | SELL | 15,000 | $22.97 | $344.6K |
| Ordentlich Peter | Chief Scientific Officer | 2020-11-23 | SELL | 29,972 | $23.16 | $694.2K |
| Morrison Briggs | CEO | 2020-11-10 | SELL | 80,404 | $20.04 | $1611.3K |
| Metzger Michael A | President and COO | 2020-11-04 | SELL | 100,000 | $20.31 | $2031K |
| Morrison Briggs | CEO | 2020-02-04 | BUY | 12,500 | $8 | $100K |
| Morrison Briggs | CEO | 2019-10-10 | BUY | 11,000 | $5.4 | $59.4K |
| Morrison Briggs | CEO | 2019-05-13 | BUY | 20,400 | $7.46 | $152.2K |
| Meyers Michael L. | SVP, Chief Medical Officer | 2019-03-21 | BUY | 8 | $4.87 | $0K |
| Meyers Michael L. | SVP, Chief Medical Officer | 2019-03-21 | BUY | 1,104 | $4.92 | $5.4K |
| Meyers Michael L. | SVP, Chief Medical Officer | 2018-10-30 | BUY | 200 | $4.79 | $1K |
| Ordentlich Peter | Chief Scientific Officer | 2018-04-03 | SELL | 7,500 | $15 | $112.5K |
| Ordentlich Peter | Chief Scientific Officer | 2017-05-17 | SELL | 5,000 | $15 | $75K |
| ROYSTON IVOR | Director | 2016-03-08 | BUY | 150,000 | $12 | $1800K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked